Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results. Appendix 5 of 5

25 Feb 2010 07:01

RNS Number : 6577H
Royal Bank of Scotland Group PLC
25 February 2010
 



 

 

 

 

 

 

 

 

 

 

Appendix 5

 

Annual results 2009

 

Revisions

 

 Appendix 5 - Revisions

 

Divisional revisions

Divisional results have been revised to reflect the transfer of RBS Sempra Commodities to Non-Core from GBM. These changes do not affect the Group's results.

 

Quarter ended 30 September 2009

Quarter ended 30 June 2009

 Previously 

 reported 

Adjustment 

Revised 

 Previously 

 reported 

Adjustment 

Revised 

Global Banking & Markets

£m 

£m 

£m 

 

£m 

£m 

£m 

Net interest income

447 

447 

660 

660 

Non-interest income

1,412 

(114)

1,298 

1,650 

(207)

1,443 

Direct expenses

- staff costs

(760)

39 

(721)

(762)

82 

(680)

- other costs

(261)

21 

(240)

(231)

27 

(204)

Impairment losses

(272)

(272)

31 

31 

Operating profit

375 

(54)

321 

1,147 

(98)

1,049 

£bn 

£bn 

£bn 

 

£bn 

£bn 

£bn 

Loans and advances (including banks)

157.0 

(0.7)

156.3 

156.0 

(0.8)

155.2 

Reverse repos

75.4 

75.4 

75.2 

75.2 

Securities

117.6 

117.6 

115.5 

115.5 

Cash and eligible bills

63.8 

63.8 

51.5 

51.5 

Other

50.8 

(4.8)

46.0 

46.2 

(5.7)

40.5 

Total third party assets (excluding

derivatives mark to market)

464.6 

(5.5)

459.1 

444.4 

(6.5)

437.9 

Customer deposits (excluding repos)

58.1 

(1.3)

56.8 

65.0 

(1.6)

63.4 

Risk-weighted assets

131.9 

(10.4)

121.5 

122.4 

(9.9)

112.5 

Quarter ended 31 March 2009

Quarter ended 31 December 2008

 Previously 

 reported 

Adjustment 

Revised 

 Previously 

 reported 

Adjustment 

Revised 

Global Banking & Markets

£m 

£m 

£m 

 

£m 

£m 

£m 

Net interest income

812 

812 

1,054 

1,054 

Non-interest income

4,527 

(247)

4,280 

(2,850)

(404)

(3,254)

Direct expenses

- staff costs

(1,001)

113 

(888)

(178)

160 

(18)

- other costs

(300)

26 

(274)

(421)

24 

(397)

Impairment losses

(269)

(269)

(505)

(502)

Operating profit/(loss)

3,576 

(108)

3,468 

(3,102)

(217)

(3,319)

 

 

 

 

 

 

 

Loans and advances (including banks)

206.5 

(1.2)

205.3 

225.5 

(1.3)

224.2 

Reverse repos

80.6 

80.6 

88.8 

88.8 

Securities

124.3 

124.3 

127.5 

127.5 

Cash and eligible bills

28.6 

28.6 

20.2 

20.2 

Other

43.1 

(5.7)

37.4 

42.9 

(4.9)

38.0 

Total third party assets (excluding

derivatives mark to market)

483.1 

(6.9)

476.2 

504.9 

(6.2)

498.7 

Customer deposits (excluding repos)

81.8 

(1.7)

80.1 

88.6 

(0.8)

87.8 

Risk-weighted assets

148.6 

(10.7)

137.9 

162.4 

(10.6)

151.8 

 

Appendix 5 - Revisions

 

Quarter ended 30 September 2009

Quarter ended 30 June 2009

 Previously 

 Reported

Adjustment 

Revised 

 Previously 

 reported 

Adjustment 

Revised 

Non-Core

£m 

£m 

£m 

£m 

£m 

£m 

Net interest income

287 

287 

274 

274 

Non-interest income

(347)

114 

(233)

(1,168)

207 

(961)

Direct expenses

- staff costs

(111)

(39)

(150)

(71)

(82)

(153)

- other costs

(223)

(21)

(244)

(220)

(27)

(247)

Impairment losses

(2,066)

(2,066)

(3,516)

(3,516)

Operating loss

(2,718)

54 

(2,664)

(4,975)

98 

(4,877)

£bn 

£bn 

£bn 

 

£bn 

£bn 

£bn 

Total third party assets (including

derivatives)

220.2 

12.8 

233.0 

231.9 

14.6 

246.5 

Loans and advances to customers - gross

158.7 

0.4 

159.1 

163.6 

0.5 

164.1 

Customer deposits

14.7 

1.3 

16.0 

13.4 

1.6 

15.0 

Risk-weighted assets

190.3 

10.4 

200.7 

164.1 

9.9 

174.0 

 

Quarter ended 31 March 2009

Quarter ended 31 December 2008

 Previously 

 reported 

Adjustment 

Revised 

 Previously 

 Reported

Adjustment 

Revised 

Non-Core

£m 

£m 

£m 

£m 

£m 

£m 

Net interest income

395 

395 

765 

765 

Non-interest income

(2,418)

247 

(2,171)

(3,099)

404 

(2,695)

Direct expenses

- staff costs

(188)

(113)

(301)

(110)

(160)

(270)

- other costs

(230)

(26)

(256)

(321)

(24)

(345)

Impairment losses

(1,828)

(1,828)

(3,358)

(3)

(3,361)

Operating loss

(4,588)

108 

(4,480)

(6,467)

217 

(6,250)

 

 

 

 

 

 

 

Total third party assets (including

derivatives)

297.1 

17.6 

314.7 

325.1 

17.8 

342.9 

Loans and advances to customers - gross

183.1 

0.6 

183.7 

190.6 

0.8 

191.4 

Customer deposits

21.9 

1.8 

23.7 

26.6 

0.8 

27.4 

Risk-weighted assets

163.7 

10.7 

174.4 

160.3 

10.6 

170.9 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PGUUPPUPUUPA
Date   Source Headline
22nd Jul 20202:00 pmRNSChange of Name
16th Jul 20207:00 amRNSIntention to Change Name on 22 July 2020
1st Jul 202012:29 pmRNSDirector/PDMR Shareholding
30th Jun 20204:26 pmRNSTotal Voting Rights
29th Jun 20207:00 amRNSNotice of Redemption
25th Jun 20209:19 amRNSRBSG pricing of US$1.5bn Additional Tier 1 Notes
23rd Jun 20207:00 amRNSChanges to the Alternative Remedies Package
11th Jun 20205:31 pmRNSPublication of Supplementary Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
8th Jun 20204:15 pmRNSHolding(s) in Company
8th Jun 20203:38 pmRNSTotal Voting Rights and Capital
8th Jun 20203:20 pmRNSDirector/PDMR Shareholding
29th May 20203:09 pmRNSDirector/PDMR Shareholding
29th May 20202:25 pmRNSTotal Voting Rights
29th May 202012:52 pmRNSDividend Declaration
21st May 202010:15 amRNSAdditional Listing
20th May 20207:04 amRNSRBSG pricing of US$1.6bn of Senior Notes
14th May 20201:00 pmRNSDirector/PDMR Shareholding
13th May 20204:01 pmRNSPublication of Final Terms
12th May 202011:16 amRNSQ1 2020 Pillar 3 Supplement
5th May 20204:57 pmRNSPublication of Supplementary Prospectus
1st May 20204:20 pmRNSPublication of Suppl.Prospcts
1st May 20207:00 amRNSQ1 Interim Management Statement
30th Apr 202012:20 pmRNSTotal Voting Rights
29th Apr 20204:33 pmRNSResult of AGM
29th Apr 20203:01 pmRNSAGM Statement
28th Apr 20203:51 pmRNSDirector/PDMR Shareholding
27th Apr 20204:40 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
27th Apr 20203:58 pmRNSDisclosure of rights attached to equity shares
20th Apr 202012:38 pmRNSDividend Declaration
14th Apr 20204:21 pmRNSVirtual Shareholder Event – 29 April 2020
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
6th Apr 20202:14 pmRNSBlock Listing Six Monthly Return
3rd Apr 20204:11 pmRNSAmendment of Final Terms
3rd Apr 20203:24 pmRNSNotice of AGM
2nd Apr 202012:11 pmRNSDirector/PDMR Shareholding
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202011:34 amRNSRoyal Bank of Scotland Group
1st Apr 20207:00 amRNSResponse to Covid-19
26th Mar 20204:42 pmRNSSecond Price Monitoring Extn
26th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn
25th Mar 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.